On the mechanism of the Leuckart reaction. Enantiospecific preparation of (1R,2R)- and (1S,2S)-N-(3,3-dimethyl-2-formylamino-1-norbornyl)acetamide
Ana Martı́nez(Consejo Superior de Investigaciones Científicas), M. P. Martinez Alcazar(Universidad San Pablo CEU), Enrique Teso Vilar(Universidad Nacional de Educación a Distancia), R. Macias San Antonio(Universidad Complutense de Madrid), Amelia Garcı́a Fraile, Paloma Martínez‐Ruiz(Universidad Complutense de Madrid)
Cited by 21
Related Papers
COVID-19: Drug Targets and Potential Treatments
|Journal of Medicinal Chemistry|2020|469
First Non-ATP Competitive Glycogen Synthase Kinase 3 β (GSK-3β) Inhibitors: Thiadiazolidinones (TDZD) as Potential Drugs for the Treatment of Alzheimer's Disease
|Journal of Medicinal Chemistry|2002|448
GSK-3 Inhibitors: Preclinical and Clinical Focus on CNS
|Frontiers in Molecular Neuroscience|2011|348
Glycogen synthase kinase 3 (GSK‐3) inhibitors as new promising drugs for diabetes, neurodegeneration, cancer, and inflammation
|Medicinal Research Reviews|2002|334
TNFα disrupts blood brain barrier integrity to maintain prolonged depressive-like behavior in mice
|Brain Behavior and Immunity|2018|293